BE Pharma Management
Timeline
20 events since 2015Board
Filings
Financial
Establishments
201620182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 15 days before the deadline
2025
Highest result from 2016 to 2025 net €45,003 ▲51.6% The operating result of €73,819 and the net result of €45,003 are both a record.
Equity above €150,000 equity €194,360 ▲30.1% After 4 profitable years in a row, equity reaches €194,360.
- General meeting, 16-09-2025
- Director appointment, Bart Van Herrewegen (director (not named in the articles))
Registered in the Peppol Directory Reachable for e-invoices through 0208:0630764571
Annual accounts 2024 filed PDFabbreviated format · 14 days before the deadline
2024
Annual accounts 2023 filed PDFabbreviated format · 12 days before the deadline
2023
Annual accounts 2022 filed PDFabbreviated format · 29 days late
2022
Back to profit net €2,303 The net result is €2,303, after one loss-making year.
Annual accounts 2021 filed PDFmicro format · 11 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 5 days before the deadline
2020
Annual accounts 2019 filed PDFmicro format · 68 days late
2019
Back to profit net €6,526 The net result is €6,526, after one loss-making year.
Annual accounts 2018 filed PDFmicro format · on the deadline day
Company renamed from BE PHARMA PUURS to BE PHARMA MANAGEMENTChange of role: Eveline Lieve Michaël VAN HEMELRIJK, from manager to statutory director · “Het aanleggen, het oordeelkundig uitbouwen en beheren van een onroerend vermogen: alle verrichtingen met…” (deed in Dutch) · Legal-form conversion: from private limited company (pre-2019) to private limited company6 points ▸
- Name change, BE PHARMA MANAGEMENT
- Net-asset statement, 31-03-2019
- Legal-form conversion, from private limited company (pre-2019) to private limited company
- Director appointment, Eveline Lieve Michaël VAN HEMELRIJK (statutory director), mentioned twice in the deed
- Director resignation, Eveline Lieve Michaël VAN HEMELRIJK (manager)
- Registered office clause, Guido Gezellelaan 37, 2870 Puurs-Sint-Amands (Puurs)
- The deed holds 8 more points.
2018
Weakest financial year net -€12,658 The net result drops to -€12,658, the lowest from 2016 to 2025. It recovers the following year.
Annual accounts 2017 filed PDFmicro format · 25 days before the deadline
2017
Annual accounts 2016 filed PDFabbreviated format · 41 days before the deadline
2015
First establishment BE PHARMA PUURS, G. Gezellelaan 37, Puurs-Sint-Amands
Incorporation PDFpublished on 26-05-2015
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank